ADOCIA Announces its Annual Shareholders’ Meeting to be Held on June 13th, 2024 in Paris

LYON, France--(BUSINESS WIRE)-- #BIOTECH--Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and obesity, announced today that it will hold its annual shareholders’ meeting (“AGM”) on June 13th, 2024, at 10:30 am, in the Jones Day’s offices, Hotel de Talleyrand, 2 rue Saint Florentin, 75001 Paris. The notice of this shareholders’ meeting serving a